Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 65-74

  Menne, Stephan ^a   Maschke, Jan ^a   Tolle, Tanja K ^b   Mengji, L U ^a   Roggendorf, Michael ^a,c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEPATITIS B CORE ANTIGEN; PEPTIDE;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; EPITOPE MAPPING; HEPATITIS B; HEPATITIS B VIRUS; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; WOODCHUCK;

EID: 0031060105     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.65-74.1997     Document Type: Article

References (48)

1. Beasly, R. P., L. Trepo, C. E. Stevens, and W. Szmuness. 1977. The e-antigen and vertical transmission of hepatitis B surface antigen. Am. J. Epidemiol. 105:914-918.
2. Bertoletti, A., A. Sette, F. V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature (London) 369:407.
3. Bertoletti, A., C. Ferrari, F. Fiaccadori, A. Penna, R. Margolskee, H. J. Schlicht, P. Fowler, S. Guilhot, and F. V. Chisari. 1991. HLA class-I human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc. Natl. Acad. Sci. USA 88:10445-10449.
4. Bertram, E. M., R. G. Wilkinson, B. A. Lee, A. R. Jilbert, and I. Kotlarski. Identification of duck T lymphocytes using an anti-human T cell (CD3) antiserum. Vet. Immunol. Immunopathol., in press.
5. Buendia, M. A. 1994. Hepatitis B viruses and liver cancer: the woodchuck model, p. 183-187. In A. Mirson, J. Neil, and M. McCrae (ed.), Viruses and cancers. Symposium for General Microbiology. Cambridge University Press, Cambridge.
6. Cote, P. J., and J. L. Gerin. 1995. In vitro activation of woodchuck lymphocytes measured by radiopurine incorporation and interleukin-2 production: implications for modelling immunity and therapy in hepatitis B virus infection. Hepatology 22:687-699.
7. Fekadu, M., J. W. Sumner, J. H. Shaddock, D. W. Sanderlin, and G. M. Baer. 1992. Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein. J. Virol. 66:2601-2604.
8. Ferrari, C., A. Bertoletti, A. Penna, A. Cavalli, A. Valli, G. Missale, M. Pilli, P. Fowler, T. Giuberti, F. V. Chisari, and F. Fiaccadori. 1991. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J. Clin. Invest. 88:214-222.
9. Ferrari, C., A. Penna, A. Bertoletti, A. Valli, A. Degli Antoni, T. Giuberti, A. Cavalli, M. A. Petit, and F. Fiaccadori. 1990. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 145:3442-3449.
10. Ferrari, C., A. Penna, P. Sansoni, T. Giuberti, T. M. Neri, F. V. Chisari, and F. Fiaccadori. 1986. Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. Clin. Exp. Immunol. 67:497-506.
11. Ferrari, C., A. Penna, T. Giuberti, M. J. Tong, E. Ribera, F. Fiaccadori, and F. V. Chisari. 1987. Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J. Immunol. 139:2050-2058.
12. Franco, A., C. Ferrari, A. Sette, and F. V. Chisari. 1995. Viral mutations, TCR antagonism and escape from the immune response. Curr. Opin. Immunol. 7:524-531.
13. Galibert, F., T. N. Chen, and E. Mandart. 1982. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J. Virol. 41:51-65.
14. Gerin, J. L., P. J. Cote, B. E. Korba, R. H. Miller, R. H. Purcell, and B. C. Tennant. 1991. Hepatitis B virus and liver cancer: the woodchuck as an experimental model of hepadnavirus induced liver cancer, p. 556-559. In F. B. Hollinger, S. M. Lemon, and H. Margolis (ed.), Viral hepatitis and liver disease. The Williams & Wilkins Co., Baltimore. Md.
15. Greaves, M. F., and G. Brown. 1974. Purification of human T and B lymphocytes. J. Immunol. 112:420-423.
16. Inoue, M., S. Kakumu, K. Yoshioka, Y. Tsutsumi, T. Wakita, and M. Arao. 1989. Hepatitis B core antigen specific IFN-gamma production in peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. J. Immunol. 142:4006-4012.
17. Iwarson, S., E. Tabor, H. C. Thomas, P. Snoy, and R. J. Gerety. 1985. Protection against hepatitis B virus infection by immunization with hepatitis B C-antigen. Gastroenterology 88:763-767.
18. Jones, M., J. L. Cordell, A. D. Beyers, A. G. D. Tse, and D. Y. Mason. 1993. Detection of T and B cells in many animal species using cross reactive anti-peptide antibodies. J. Immunol. 150:5429-5435.
19. Julius, M. H., E. Simpson, and L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645-649.
20. + T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J. Virol. 69:3358-3368.
21. Jung, M.-C., U. Spengler, W. Schraut, R. Hoffmann, R. Zachoval, J. Eisenburg, D. Eichenlaub, G. Riethmüller, G. Paumgartner, H. W. L. Ziegler-Heitbrock, H. Will, and G. R. Pape. 1991. Hepatitis B virus antigen specific T-cell activation in patients with acute and chronic hepatitis B. J. Hepatol. 13:310-317.
22. Kajino, K., A. R. Jilbert, J. Saputelli, C. E. Aldrich, J. Cullen, and W. S. Mason. 1994. Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J. Virol. 68:5792-5803.
23. Klavinskis, L. S., J. L. Whitton, E. Joly, and M. B. A. Oldstone. 1990. Vaccination and protection from a lethal viral infection, identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 178:393-400.
24. Korba, B. E., P. J. Cote, and J. L. Gerin. 1988. Mitogen-induced replication of woodchuck hepatitis viruses in cultured peripheral blood lymphocytes. Science 241:1213-1216.
25. 3H]adenine uptake in the woodchuck model. Clin. Immunol. Immunopathol. 78:223-227.
26. Löhr, H. F., W. Weber, J. Schlaak, B. Goergen, K.-H. Meyer zum Büschenfelde, and G. Gerken. 1995. Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. Hepatology 22:61-68.
27. Lowry, R. P., A. E. Person, J. E. Goguen, C. B. Carpenter, and M. R. Garovoy. 1978. Technical modifications for antibody-dependent cell-mediated cytotoxicity versus separated T and B lymphocytes: T- and B-cell separation by nylon wool columns. Transplant. Proc. 10:833-837.
28. 3H]adenine incorporation. Arch. Virol., in press.
29. Milich, D. R., A. McLachlan, A. Moriarty, and G. B. Thornton. 1987. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg. J. Immunol. 139:1223-1231.
30. Milich, D. R., A. McLachlan, G. B. Thornton, and J. L. Hughes. 1987. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature (London) 329:547-549.
31. Milich, D. R., J. L. Hughes, A. McLachlan, G. B. Thornton, and A. Moriarty. 1988. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope. Proc. Natl. Acad. Sci. USA 85:1610-1614.
32. Murray, K., S. A. Bruce, A. Hinnen, P. Wingfield, P. M. C. A. van Erd, A. de Reus, and H. Schellekens. 1984. Hepatitis B antigens made in microbial cells immunize against viral infection. EMBO J. 3:645-650.
33. Murray, K., S. A. Bruce, P. Wingfield, P. M. C. A. van Erd, A. de Reus, and H. Schellekens. 1987. Protective immunization against hepatitis B virus infection by immunization with an internal antigen of the virus. J. Med. Virol. 23:101-107.
34. Oldstone, M. B. A., A. Tishon, M. Eddleston, J. C. de la Torre, T. McKee, and J. L. Whitton. 1993. Vaccination to prevent persistent viral infection. J. Virol. 67:4372-4378.
35. Popper, H., J. W.-K. Shih, J. L. Gerin, D. C. Wong, B. H. Hoyer, W. T. London, D. L. Sly, and R. H. Purcell. 1981. Woodchuck hepatitis and hepatocellular carcinoma: correlation of histologic with virologic observations. J. Hepatol. 1:19-28.
36. Roggendorf, M., and T. K. Tolle. 1995. The woodchuck: an animal model for hepatitis B virus infection in man. Intervirology 38:100-112.
37. Roos, S., K. Fuchs, and M. Roggendorf. 1989. Protection of woodchucks from infection with woodchuck hepatitis virus (WHV) by immunization with recombinant core protein. J. Gen. Virol. 70:2087-2095.
38. Sanger, F., S. Nicklen, and A. R. Coulsen. 1977. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
39. Schödel, F., G. Neckermann, D. Peterson, K. Fuchs, S. Fuller, H. Will, and M. Roggendorf. 1993. Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nucleocapsid antigen protects woodchucks from woodchuck hepatitis virus infection. Vaccine 11:624-628.
40. Snyder, R. L. 1982. Chronic hepatitis and hepatocellular carcinoma associated with woodchuck hepatitis virus. Am. J. Pathol. 107:422-425.
41. Sumner, J. W., M. Fekadu, J. H. Shaddock, J. J. Esposito, and W. J. Bellini. 1991. Protection of mice with vaccinia virus recombinants that express the rabies nucleoprotein. Virology 183:703-710.
42. Sylvan, S. P. E., U. B. Hellström, and B. Fiehming. 1987. Characterization of cell mediated immune responses to the hepatitis B core protein in man. Clin. Exp. Immunol. 68:233-241.
43. Vitiello, A., G. Ishioka, H. M. Grey, R. Rose, P. Farness, R. LaFond, L. Yuan, F. V. Chisari, J. Furze, R. Bartholomeuz, and R. W. Chesnut. 1995. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest. 95:341-349.
44. Watari, E., B. Dietzschold, G. Szokan, and E. Heber-Katz. 1987. A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2. J. Exp. Med. 165:459-470.
45. Werner, C., P. T. Klouda, M. C. Corréa, P. Vassalli, and M. Jeannet. 1977. Isolation of B and T lymphocytes by nylon fiber columns. Tissue Antigens 9:227-229.
46. Wong, D. M., and K. K. Mittal. 1981. HLA-DR typing: a comparison between nylon wool adherence and T cell rosetting in the isolation of B cells. J. Immunol. Methods 46:177-186.
47. Zamorano, P., A. Wigdorovitz, M. Perez-Filgueira, C. Carrillo, J. M. Escribano, A. M. Sadir, and M. V. Borca. 1995. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice. Virology 212:614-621.
48. Zamorano, P., A. Wigdorovitz, M. T. Chaher, F. M. Fernandez, C. Carrillo, F. E. Marcovecchio, A. M. Sadir, and M. V. Borca. 1994. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 0 1 Campos. Virology 201:383-387.